Ariana Gatt

Dr. Ariana Gatt

Queen Square Brain Bank, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in Development
Verified
Journal Article
Open access
PDF file
AAAmélie Avet-Rochex
Amélie Avet-Rochex
AKAamna K. Kaul
Aamna K. Kaul
AGAriana Gatt
Ariana Gatt
HMHelen McNeill
Helen McNeill
JBJoesph Matthew Bateman
Joesph Matthew Bateman
Glial cells are essential for the development and function of the nervous system. In the mammalian brain, vast numbers of glia of several different functional types are generated during late embryonic and early foetal development. However, the molecular cues that instruct gliogenesis and determine glial cell type are poorly understood. During post-embryonic development, the number of glia in the Drosophila larval brain increases dramatically, potentially providing a powerful model for understanding gliogenesis. Using glial-specific clonal analysis we find that perineural glia and cortex glia proliferate extensively through symmetric cell division in the post-embryonic brain. Using pan-glial inhibition and loss-of-function clonal analysis we find that Insulin-like receptor (InR)/Target of rapamycin (TOR) signalling is required for the proliferation of perineural glia. Fibroblast growth factor (FGF) signalling is also required for perineural glia proliferation and acts synergistically with the InR/TOR pathway. Cortex glia require InR in part, but not downstream components of the TOR pathway, for proliferation. Moreover, cortex glia absolutely require FGF signalling, such that inhibition of the FGF pathway almost completely blocks the generation of cortex glia. Neuronal expression of the FGF receptor ligand Pyramus is also required for the generation of cortex glia, suggesting a mechanism whereby neuronal FGF expression coordinates neurogenesis and cortex gliogenesis. In summary, we have identified two major pathways that control perineural and cortex gliogenesis in the post-embryonic brain and have shown that the molecular circuitry required is lineage specific.

8 February 2016 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
AGAriana Gatt
Ariana Gatt
ODOlivia F. Duncan
Olivia F. Duncan
JAJohannes Attems
Johannes Attems
PFPaul T. Francis
Paul T. Francis
CBClive Mr. Ballard
Clive Mr. Ballard
JBJoesph Matthew Bateman
Joesph Matthew Bateman

6 September 2019 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
GWGareth Williams
Gareth Williams
AGAriana Gatt
Ariana Gatt
ECEarl Clarke
Earl Clarke
JCJonathan Corcoran
Jonathan Corcoran
PDPatrick Doherty
Patrick Doherty
CBClive Ballard
Clive Ballard
Alzheimer’s disease is a complex disorder encompassing multiple pathological features with associated genetic and molecular culprits. However, target-based therapeutic strategies have so far proved ineffective. The aim of this study is to develop a methodology harnessing the transcriptional changes associated with Alzheimer’s disease to develop a high content quantitative disease phenotype that can be used to repurpose existing drugs. Firstly, the Alzheimer’s disease gene expression landscape covering severe disease stage, early pathology progression, cognitive decline and animal models of the disease has been defined and used to select a set of 153 drugs tending to oppose disease-associated changes in the context of immortalised human cancer cell lines. The selected compounds have then been assayed in the more biologically relevant setting of iPSC-derived cortical neuron cultures. It is shown that 51 of the drugs drive expression changes consistently opposite to those seen in Alzheimer’s disease. It is hoped that the iPSC profiles will serve as a useful resource for drug repositioning within the context of neurodegenerative disease and potentially aid in generating novel multi-targeted therapeutic strategies.

21 October 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
UCUmut Cagin
Umut Cagin
ODOlivia F. Duncan
Olivia F. Duncan
AGAriana Gatt
Ariana Gatt
MDMarc S. Dionne
Marc S. Dionne
SSSean Sweeney
Sean Sweeney
JBJoesph Matthew Bateman
Joesph Matthew Bateman
Significance: Mitochondrial retrograde signaling is an ancient mechanism defined as the cellular response to changes in the functional state of mitochondria. We find that in the Drosophila nervous system, mitochondrial dysfunction activates a retrograde response controlling hundreds of nuclear genes. We identify the Drosophila ortholog of hypoxia inducible factor alpha (HIFα) as a potential regulator of the neuronal mitochondrial retrograde response. Remarkably, knockdown of HIFα restores neuronal function without affecting the primary mitochondrial defect. Mitochondrial retrograde signaling is therefore partly responsible for neuronal pathology. Knockdown of HIFα also restores function in Drosophila models of Leigh syndrome and Parkinson’s disease. Our results demonstrate that mitochondrial retrograde signaling has a key role in neuronal homeostasis and that manipulation of retrograde signaling may have therapeutic potential in mitochondrial diseases and Parkinson’s.

1 December 2013 in Neuroscience Letters
Verified
Journal Article
Closed access
AGAriana Gatt
Ariana Gatt
EJEmma L. Jones
Emma L. Jones
PFPaul T. Francis
Paul T. Francis
CBClive Mr. Ballard
Clive Mr. Ballard
JBJoesph Matthew Bateman
Joesph Matthew Bateman

22 January 2022 in Neuropathology and Applied Neurobiology
Verified
Journal Article
Open access
PDF file
RSRahul Sidhu
Rahul Sidhu
AGAriana Gatt
Ariana Gatt
PFPietro Fratta
Pietro Fratta
TLTammaryn Lashley
Tammaryn Lashley
ABAlexander Bampton
Alexander Bampton
Nuclear depletion and cytoplasmic mislocalisation of the RNA‐binding protein heterogeneous ribonucleoprotein K (hnRNP K) within pyramidal neurons of the frontal cortex have been shown to be a common neuropathological feature in frontotemporal lobar degeneration (FTLD) and elderly control brain. Here, we describe a second neuronal subtype vulnerable to mislocalisation within the dentate nucleus of the cerebellum. In contrast to neurons within the cerebellar cortex that typically exhibited normal, nuclear staining, many neurons of the dentate nucleus exhibited striking mislocalisation of hnRNP K to the cytoplasm within neurodegenerative disease brain. Mislocalisation frequency in this region was found to be significantly higher in both FTLD‐TDP A and Alzheimer's disease (AD) brain than in age‐matched controls. However, within control (but not disease) subjects, mislocalisation frequency was significantly associated with age‐at‐death with more elderly controls typically exhibiting greater levels of the pathology. This study provides further evidence for hnRNP K mislocalisation being a more anatomically diverse pathology than previously thought and suggests that potential dysfunction of the protein may be more broadly relevant to the fields of neurodegeneration and ageing.